These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34141520)

  • 1. Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.
    Bayoumi A; Elsayed A; Han S; Petta S; Adams LA; Aller R; Khan A; García-Monzón C; Arias-Loste MT; Miele L; Latchoumanin O; Alenizi S; Gallego-Durán R; Fischer J; Berg T; Craxì A; Metwally M; Qiao L; Liddle C; Yki-Järvinen H; Bugianesi E; Romero-Gomez M; George J; Eslam M
    Adv Sci (Weinh); 2021 Jun; 8(11):2004168. PubMed ID: 34141520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
    Li H; Fang Q; Gao F; Fan J; Zhou J; Wang X; Zhang H; Pan X; Bao Y; Xiang K; Xu A; Jia W
    J Hepatol; 2010 Nov; 53(5):934-40. PubMed ID: 20675007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
    Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
    Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.
    Dushay J; Chui PC; Gopalakrishnan GS; Varela-Rey M; Crawley M; Fisher FM; Badman MK; Martinez-Chantar ML; Maratos-Flier E
    Gastroenterology; 2010 Aug; 139(2):456-63. PubMed ID: 20451522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.
    Shen Y; Ma X; Zhou J; Pan X; Hao Y; Zhou M; Lu Z; Gao M; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Aug; 12():124. PubMed ID: 23981342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study.
    Yan H; Xia M; Chang X; Xu Q; Bian H; Zeng M; Rao S; Yao X; Tu Y; Jia W; Gao X
    PLoS One; 2011; 6(9):e24895. PubMed ID: 21949781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
    Richter MM; Kemp IM; Heebøll S; Winther-Sørensen M; Kjeldsen SAS; Jensen NJ; Nybing JD; Linden FH; Høgh-Schmidt E; Boesen MP; Madsbad S; Schiødt FV; Nørgaard K; Schmidt S; Gluud LL; Haugaard SB; Holst JJ; Nielsen S; Rungby J; Wewer Albrechtsen NJ
    Metabolism; 2024 Jul; 156():155915. PubMed ID: 38631460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice.
    Liu XH; Graham ZA; Harlow L; Pan J; Azulai D; Bauman WA; Yarrow J; Cardozo CP
    Front Endocrinol (Lausanne); 2021; 12():668984. PubMed ID: 34046014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans.
    Kralisch S; Tönjes A; Krause K; Richter J; Lossner U; Kovacs P; Ebert T; Blüher M; Stumvoll M; Fasshauer M
    J Endocrinol; 2013 Feb; 216(2):135-43. PubMed ID: 23129782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.
    Yilmaz Y; Eren F; Yonal O; Kurt R; Aktas B; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
    Eur J Clin Invest; 2010 Oct; 40(10):887-92. PubMed ID: 20624171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.
    Jiang S; Yan C; Fang QC; Shao ML; Zhang YL; Liu Y; Deng YP; Shan B; Liu JQ; Li HT; Yang L; Zhou J; Dai Z; Liu Y; Jia WP
    J Biol Chem; 2014 Oct; 289(43):29751-65. PubMed ID: 25170079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.
    Mutanen A; Heikkilä P; Lohi J; Raivio T; Jalanko H; Pakarinen MP
    J Hepatol; 2014 Jan; 60(1):183-90. PubMed ID: 24021426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease.
    Woolsey SJ; Beaton MD; Mansell SE; Leon-Ponte M; Yu J; Pin CL; Adams PC; Kim RB; Tirona RG
    Mol Pharmacol; 2016 Oct; 90(4):437-46. PubMed ID: 27482056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet.
    Uebanso T; Taketani Y; Yamamoto H; Amo K; Tanaka S; Arai H; Takei Y; Masuda M; Yamanaka-Okumura H; Takeda E
    J Nutr Biochem; 2012 Jul; 23(7):785-90. PubMed ID: 21889884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
    Fisher FM; Chui PC; Nasser IA; Popov Y; Cunniff JC; Lundasen T; Kharitonenkov A; Schuppan D; Flier JS; Maratos-Flier E
    Gastroenterology; 2014 Nov; 147(5):1073-83.e6. PubMed ID: 25083607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet.
    Hao L; Huang KH; Ito K; Sae-Tan S; Lambert JD; Ross AC
    J Nutr; 2016 Feb; 146(2):184-90. PubMed ID: 26764334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
    Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential roles of fibroblast growth factor 21 in the brain.
    Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.